Global Contraceptives Market 2014-2018

Global Contraceptives Market 2014-2018 is a new market research publication announced by Reportstack. Contraception, also known as birth control or fertility control, refers to the use of methods or drugs or devices to prevent pregnancy as a consequence of sexual intercourse. Contraception methods can be temporary and permanent and are available to men and women. Permanent methods include male sterilization (vasectomy), and female sterilization including tubal occlusion or hysteroscopic sterilisation. Temporary methods can be hormonal and non-hormonal. The non-hormonal methods include condoms, diaphragms, sponges, withdrawal methods, cervical caps, and non-hormonal IUDs. Condoms, diaphragms, sponges, and cervical caps are also referred to as barrier contraception methods. Hormonal methods include oral contraceptive pills, contraceptive transdermal patches, vaginal rings, hormonal IUDs, and vaginal implants. Hormonal methods contain synthetic sex hormones estrogen/progestin or a combination of both which prevent ovulation and thicken cervical mucus in the female. Currently, hormonal methods can only be used by women. The development of a male hormonal contraceptive is an active research area.

The analysts forecast the Global Contraceptives market will grow at a CAGR of 5.90 percent over the period 2013-2018. The Global Contraceptives market can be segmented broadly into two divisions: Drugs and Devices. This report covers the present scenario and the growth prospects of the Global Contraceptives market for the period 2013-2018. To calculate the market size, the report considers revenue generated from the sales of various products used for contraception which include:

• Drugs (Oral Contraceptive Pills, Injectable Contraceptives, Topical Contraceptives)

• Devices (Male & Female condoms, Diaphragms, IUDs, Vaginal Rings, Female Sponges and Subdermal Contraceptive Implants)

The report Global Contraceptives Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global Contraceptives market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

Key Regions

• Americas

• EMEA     

• APAC

Key Vendors

• Actavis plc

• Bayer AG

• Johnson & Johnson’s Janssen Pharmaceuticals, Inc.

• Merck & Co.

• Pfizer, Inc.

• Teva Pharmaceutical Industries, Ltd

Other Prominent Vendors

• Adamis Pharmaceuticals

• Corp.

• Agile Therapeutics, Inc.

• ANI Pharmaceuticals, Inc.

• Ansell Ltd.

• Apothecus Pharmaceutical Corp.

• Blairex Laboratories Inc.

• Church & Dwight, Co. Inc.

• Caldwell Consumer Health, LLC.

• Ferring International Center S.A

• Fuji Latex Co., Ltd.

• HLL Lifecare Limited

• Mayer Laboratories

• Medicines 360

• Karex Berhad

• Lipocine Inc.

• Lupin Pharmaceuticals, Inc.

• Mylan Laboratories Inc.

• Okamoto Industries, Inc.

• Pantarhei Bioscience B.V.

• Paul Hartmann AG

• Reckitt Benckiser Group Plc

• The Female Health Company


Key Market Driver

• Growing Prevalence of Unwanted Pregnancies.

• For a full, detailed list, view our report.

Key Market Challenge

• Growing Prevalence of Unwanted Pregnancies.

• Introduction of Cheap Generic Contraceptives

• For a full, detailed list, view our report.

Key Market Trend

• Increasing Strategic Partnerships.

• For a full, detailed list, view our report.

Key Questions Answered in this Report

• What will the market size be in 2018 and what will the growth rate be?

• What are the key market trends?

• What is driving this market?

• What are the challenges to market growth?

• Who are the key vendors in this market space?

• What are the market opportunities and threats faced by the key vendors?

• What are the strengths and weaknesses of the key vendors?

To view the table of contents and know more details please visit Global Contraceptives Market 2014-2018.